United Therapeutics Corporation
US ˙ NasdaqGS ˙ US91307C1027

SecurityUTHR / United Therapeutics Corporation
InstitutionAdvisor Group Holdings, Inc.
Latest Disclosed Ownership4,529 shares
Latest Disclosed Value $ 2,685,929
Advisor Group Holdings, Inc. reports 58.82% decrease in ownership of UTHR / United Therapeutics Corporation

On May 15, 2026 - Advisor Group Holdings, Inc. filed a 13F-HR form disclosing ownership of 4,529 shares of United Therapeutics Corporation (US:UTHR) valued at $2,685,606 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 10,998 shares of United Therapeutics Corporation. This represents a change in shares of -58.82% during the quarter. The current value of the position is $2,490,361 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 4,529 -6,469 -58.82 2,686 -49.89 0.0023
2026-02-17 2025-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 10,998 -37,385 -77.27 5,359 -73.28 0.0034
2025-11-14 2025-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 48,383 2,301 4.99 20,055 42.97 0.0281
2025-09-04 2025-06-30 13F/A-1 NITED THERAPEUTICS CORP DEL COM 91307C102 46,082 33,662 271.03 14,027 266.43 0.0250
2025-08-13 2025-06-30 13F NITED THERAPEUTICS CORP DEL COM 91307C102 39,892 27,472 12,371 0.0143
2025-05-12 2025-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 12,420 -3,310 -21.04 3,829 -15.92 0.0085
2025-06-06 2024-12-31 13F/A-1 UNITED THERAPEUTICS CORP DEL COM 91307C102 15,730 1,294 8.96 4,554 -11.97 0.0102
2025-02-07 2024-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 17,087 2,651 5,050 0.0129
2024-11-13 2024-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 14,436 2,105 17.07 5,173 31.67 0.0117
2024-08-13 2024-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 12,331 -1,254 -9.23 3,928 25.90 0.0093
2024-05-10 2024-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 13,585 -18,774 -58.02 3,121 -56.16 0.0070
2024-02-12 2023-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 32,359 -1,915 -5.59 7,116 -8.07 0.0125
2023-11-13 2023-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 34,274 24,054 235.36 7,741 243.13 0.0114
2023-08-21 2023-06-30 13F/A-1 UNITED THERAPEUTICS CORP DEL COM 91307C102 10,220 -89 -0.86 2,256 -2.25 0.0041
2023-08-10 2023-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 15,055 4,746 2,251 0.0006
2023-05-12 2023-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 10,309 -4,303 -29.45 2,309 -43.21 0.0043
2023-02-10 2022-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 14,612 8,887 155.23 4,065 239.23 0.0082
2022-11-14 2022-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 5,725 463 8.80 1,198 -3.39 0.0027
2022-08-10 2022-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 5,262 -230 -4.19 1,240 -4.54 0.0027
2022-05-04 2022-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 5,492 -498 -8.31 1,299 0.46 0.0025
2022-02-03 2021-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 5,990 2,731 83.80 1,293 114.43 0.0024
2021-11-05 2021-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 3,259 208 6.82 603 10.04 0.0013
2021-08-02 2021-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 3,051 161 5.57 548 12.53 0.0012
2021-05-13 2021-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 2,890 290 11.15 487 22.98 0.0012
2021-02-10 2020-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 2,600 -50 -1.89 396 44.53 0.0011
2020-11-12 2020-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 2,650 143 5.70 274 -9.57 0.0008
2020-08-14 2020-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 2,507 1,388 124.04 303 180.56 0.0010
2020-05-18 2020-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 1,119 1,119 108 0.0004
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.